| Trial ID: | L5825 |
| Source ID: | NCT00256256
|
| Associated Drug: |
Glucagon-Like-Peptide-1
|
| Title: |
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Stroke|Myocardial Infarction
|
| Interventions: |
DRUG: glucagon-like-peptide-1
|
| Outcome Measures: |
Primary: FDG-uptake in the brain and heart visualized by Positron emission tomography with and without GLP-1, After 4 hours of GLP-infusion | Secondary: Laboratory values (insulin secretion and counter-regulatory hormones), During 7 hours of clamp and GLP-1/placebo infusion
|
| Sponsor/Collaborators: |
Sponsor: University of Aarhus
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2005-11
|
| Completion Date: |
2007-01
|
| Results First Posted: |
|
| Last Update Posted: |
2007-10-30
|
| Locations: |
Department of pharmacology, Aarhus university, Aarhus, 8000, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00256256
|
